As part of the Danaher family of global life science and technology innovators, SCIEX has led the field of mass spectrometry for more than 40 years. From the moment we launched the first ever commercially successful triple quad in 1981, we have continued to develop groundbreaking technologies and solutions that have influenced life-changing research and clinical diagnostic outcomes.
ONO PHARMACEUTICAL CO., LTD.
Ono Pharmaceutical Co., Ltd., headquartered in Osaka, Japan, is an R&D-oriented pharmaceutical company. Upholding the corporate philosophy “Dedicated to Man’s Fight against Disease and Pain” Ono makes united efforts to create innovative drugs that are globally competitive.
For more information, please visit the company’s website at https://www.ono.co.jp/eng/index.html
MOCHIDA PHARMACEUTICAL CO.,LTD.
About Mochida Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. has been committed to research and development of innovative pharmaceutical products since its establishment thereby providing distinctive medicines to the medical field. Currently, the core pharmaceutical business focuses resources on the targeted areas of cardiovascular medicine, obstetrics and gynecology, dermatology, psychiatry and gastroenterology, while also providing medicine for intractable disease as well as generics including biosimilars, to meet medical needs. For more information on Mochida Pharmaceutical Co., Ltd., please see http://www.mochida.co.jp/english/
Shimadzu Corporation is a global corporation founded in 1875 which provides high technology products and solutions for several industries including Analytical and Measuring Instruments, Medical Imaging, Aircraft Equipment and Industrial Machinery. Shimadzu systems for medical diagnostic and treatment applications and new drug research and development applications help support doctors and researchers involved in protecting people's health in an ever increasing range of applications. "Contributing to Society through Science and Technology"
Avanti Polar Lipids, Inc.
Since 1967 Avanti Polar Lipids has served the lipid community with the highest purity manufacturing, specialty products and lipid analysis.
Avanti’s eight Divisions are concentrated in one central USA location:
Research Products-Highest Purity Lipid Reagents
cGMP Manufacturing-API & Contract Manufacturing
Analytical Services-Lipid Analysis
Lipidomics-MS Standards, Antibodies & Lipid Toolbox
Formulations-Liposomes & Nanoparticles
Equipment-Liposome Production Tools
Custom Services-Synthesis & Beyond
Avanti’s clients include Pharmaceutical Industries, Nutraceutical Industries and Lipid Researchers.
Funakoshi Co., Ltd.
Funakoshi Co., Ltd. has contributed as a leader to distribute research reagents and instruments for researchers in the life science fields since its foundation. Our corporate mission is to provide products to broad range of customers throughout our worldwide network. We would like to take this opportunity to introduce selected products, which have been getting favorable response from our customers.
Cayman Chemical Company
With more than 35 years of experience in producing high quality research tools, Cayman Chemical is your partner in lipid research. Our scientists are experts in the synthesis, purification, and characterization of complex biolipids, fatty acids, and endogenous metabolites. We are renowned for our vast expertise in biochemistry involving the arachidonic acid cascade, resolvins, cannabinoids, and many other biochemicals, which has led to the production of a growing library of qualitative research chemicals and quantitative MaxSpecR standards for lipidomic and metabolomic studies. We also offer custom organic synthesis services for unique compounds and a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Larodan makes a comprehensive range of research grade lipids for use as analytical standards and reagents with customers all over the world. Our products include all kinds of lipids, from simple fatty acids and methyl esters to complex oxylipins, glycerides and phospholipids. Our facilities are located at the Karolinska Institute in Stockholm, Sweden and we have a representative office in Michigan in the US.
Solutex is deeply committed to research, development and innovation in the field of essential fatty acids and their metabolites. Therefore, we are testing our products in clinical studies; such as Lipinova in several health conditions with failed or uncompleted resolution of inflammatory processes.
Lipinova is a proprietary natural Omega-3 fraction that is standarized on Specialized Pro-Resolving Mediators (17HDHA, 18HEPE and 14HDHA). Lipinova in the diet supports the natural immune response by rescuing depleted levels of these essential metabolites SPMS.
Solutex is specialized in delivering:
High-purity premium concentrates of Omega-3 EPA, DHA and tailored ratios.
API active pharmaceutical ingredient.
Lipidomic analyses of biological samples.
NITTO PHARMACEUTICAL INDUSTRIES, LTD
Nitto Pharma, a pharmaceutical company based in Kyoto, Japan since 1947, is conducting cultivation of beneficial bacteria for human health and enhancing researches on functionality of gut microbes and its metabolites called “Postbiotics”. Currently, Nitto Pharma is pursuing drug discoveries harnessing both of the gut microbes and its lipid metabolites in parallel to establishing the extensive libraries of both of them.
Agilent Technologies Japan, Ltd.
Agilent was created when it spun off from Hewlett-Packard Company in 1999.It is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions.It focuses its expertise on key markets such as food, Research, Environmental and Forensics, where we help our customers achieve their goals.
Ambiotis is the first CRO world wide working on the active resolution of inflammation. Since its creation more than 10 years ago, Ambiotis leads R&D programs and investigates the naturally occurring mechanisms involved in the end of the inflammatory process in the aim of favouring them thanks to new molecules. Pioneer in this field, Ambiotis has built a strong expertise in both cell/animal models and analytical measurement of resolutive bioactive lipids, namely Specialized Pro-Resolving Mediators or SPMs. This combination is the key to ensure a thorough understanding of the finely tuned mechanisms of this biological process. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. The company thus helps them put faster on the market always more efficient and innovative compounds.
The ITO EN started our business as a small green tea company in Japan in 1964. Then, we entered the beverage business in 1980 with the development and launch of the world’s first canned oolong tea, a sugar-free, tea-based beverage. Working based on our product development concept of “natural, healthy, safe, well-designed and delicious” and paying particular attention to our raw materials, we have introduced numerous innovations and solidified our foundations as Japan’s No.1 tea company; with a central focus on leaf tea, matcha (powdered green tea) and tea-based drink products.
Our goal is to become a “Global Tea Company.” Our efforts to achieve this are based on the corporate credo of integrity, hard work and trust that has been the foundation of ITO EN since its establishment. We are working to engage in business that leads to sustainable growth, with the goal of contributing to the well-being of our customers around the world and helping each individual enjoy a fulfilling lifestyle.
Progress in Lipids Research
Progress in Lipids Research publishes invited reviews on recent progress in lipids and sets current research against its historical background. The journal focusses on the application of biochemistry, chemistry and physiology of lipids to biotechnology, the fats and oils industry and medicine and on newer dimensions such as lipid biophysics, especially with relevance to membranes and lipoproteins, and basic liposome research.
Progress in Lipids Research is published by Elsevier and has a CiteScore™ of 9.64 (Powered by Scopus©) and an Impact Factor* of 8.435. *Journal Citation Reports© (Clarivate Analytics, 2017).
BBA Molecular and Cell Biology of Lipids
BBA Molecular and Cell Biology of Lipids publishes papers on original research dealing with novel aspects of molecular genetics related to the lipidome, the biosynthesis of lipids, the role of lipids in cells and whole organisms, the regulation of lipid metabolism and function, and lipidomics in all organisms. Manuscripts should significantly advance the understanding of the molecular mechanisms underlying biological processes in which lipids are involved. Papers detailing novel methodology must report significant biochemical, molecular, or functional insight in the area of lipids.
The 17th JBS Biofrontier symposium
(Sponsored The Japanese Biochemical Society [JBS])
The Uehara Memorial Foundation
Mizutani Foundation for Glycoscience
The NOVARTIS Foundation (Japan) for the Promotion of Science
The Tokyo Biochemical Research Foundation
The Naito Foundation
The Nakatomi Foundation
The Cell Science Research Foundation
The Federation Pharmaceutical Manufacturers' Associations of JAPAN